Why is fair value unavailable for Nutra Pharma Corp (OTC-NPHC) stock?

A reliable fair value estimate is not currently available for Nutra Pharma Corp (OTC-NPHC). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Nutra Pharma Corp?

The current financial health read for Nutra Pharma Corp (OTC-NPHC) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Nutra Pharma Corp's next earnings date?

The next earnings date currently listed for Nutra Pharma Corp (OTC-NPHC) is November 20, 2026.

Does Nutra Pharma Corp (OTC-NPHC) pay dividends?

The latest available data indicates no current dividend yield for Nutra Pharma Corp (OTC-NPHC).

What is the market capitalization of Nutra Pharma Corp?

The current market capitalization listed for Nutra Pharma Corp is 715.972 K.

What is the enterprise value of Nutra Pharma Corp?

The current enterprise value listed for Nutra Pharma Corp is 13.059 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Nutra Pharma Corp?

The ticker symbol for Nutra Pharma Corp is OTC-NPHC, and the stock is listed on OTC Markets.

Where is Nutra Pharma Corp (OTC-NPHC) listed?

Nutra Pharma Corp (OTC-NPHC) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Nutra Pharma Corp?

The current debt-to-total-capital ratio listed for Nutra Pharma Corp is 94.4%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Nutra Pharma Corp?

The free float listed for Nutra Pharma Corp is 99.1%. Free float helps investors understand how much of the share base is available for public trading.

Nutra Pharma Corp (NPHC) Fair Value & Stock Analysis

Nutra Pharma Corp (NPHC)

Nutra Pharma Corp. is a biopharmaceutical company listed on OTC Markets under the ticker NPHC. As a common stock issuer, it focuses on acquiring, licensing, and commercializing pharmaceutical products and technologies aimed at pain management and a range of serious medical conditions, including neurological, autoimmune, infectious, and cancer-related diseases. Its commercial products include Nyloxin and Nyloxin Extra Strength for pain relief, along with veterinary and topical pain products such as Pet Pain-Away, Equine Pain-Away, and Luxury Feet. The company also reports development programs for RPI-78M, RPI-MN, RPI-78, and RPI-70, as well as nerve agent countermeasures. Nutra Pharma was incorporated in 2000 and is based in Boca Raton, Florida.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-NPHC	Not available	Not available	Not available	Weak	0.0%	November 20, 2026	2.8x	715.972 K	13.059 M	94.4%	99.1%	-235.0	19.4%